SEATTLE, WA, Sept. 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY)
announced today that Robert Kirkman, M.D., President and Chief Executive
Officer, will present at the Rodman & Renshaw 11th Annual Healthcare
Conference taking place Sept. 9-11, 2009 in New York.
Dr. Kirkman will present at 2 p.m. Eastern Time on Thursday, Sept. 10. A
live and archived webcast of the presentation will be accessible at
http://www.wsw.com/webcast/rrshq15/onty or by visiting the Oncothyreon website
www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
